{
    "Trade/Device Name(s)": [
        "HemoNIRLab TM"
    ],
    "Submitter Information": "NIR Diagnostics Inc.",
    "510(k) Number": "K050014",
    "Predicate Device Reference 510(k) Number(s)": [
        "K853990",
        "K951485"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKS",
        "GLY"
    ],
    "Summary Letter Date": "April 14, 2005",
    "Summary Letter Received Date": "April 18, 2005",
    "Submission Date": "December 30, 2004",
    "Regulation Number(s)": [
        "21 CFR 862.7500"
    ],
    "Regulation Name(s)": [
        "Oximeter to measure hemoglobin"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Total hemoglobin",
        "Methemoglobin",
        "Carboxyhemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "HemoNIRLab TM"
    ],
    "Method(s)/Technology(ies)": [
        "Spectroscopic measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for HemoNIRLab TM spectroscopic analyzer for quantitative measurement of hemoglobin species in whole blood",
    "Indications for Use Summary": "Intended for in vitro diagnostic use by healthcare professionals in quantitative testing of whole blood for total hemoglobin, methemoglobin and carboxyhemoglobin",
    "fda_folder": "Hematology"
}